DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
C••••• B••••••••• I••
Drug Discovery & Developmentgroup grade Aoff every schedule since Mar 31, 2023sponsor unattributed
Nothing material in the last 200 days. Last change: 31 Mar 2023, Consensus mark 89¢ on cost, down from 98¢ in Q4 2022.
Mark path, consensus per quarter end
98¢ · 89¢Q4 2022 to Q1 2023
Principal held
at least $17.5M
sum of BDC pieces, a lower bound
Fair value
$16.3M
89c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 1, 2025
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Mar 31, 2023
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2023, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| H••••••• C••••••• I••• | $17.5M | 89¢ | -9 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| H••••••• C••••••• I••• | term loan first lien S••••• S••••••, M••••••• D••• O•••••• 2025, P•••• + 5.00%, F•••• rate 8.25%, 5.50% E••• Fe | $17.5M | $16.3M 89c | S+500 bp |
Capital structure as the BDCs see it
latest quarter end Mar 31, 2023
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2023 | at least $17.5M | 89c | S+500 bp | Oct 1, 2025 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2023 | 1 | $17.5M | $16.3M | 89c | 0 |
| Dec 31, 2022 | 1 | $25.0M | $25.2M | 98c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2023
- Marked down across lendersMar 31, 2023
- Marked down (one lender)Mar 31, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- C••••• B•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Drug Discovery & Developmentreportedas one filer wrote it